The Leukemia & Lymphoma Society® (LLS), a global leader in the fight against blood cancer, and Tasso announced a collaboration to accelerate blood cancer research. The relationship will combine Tasso’s signature capillary blood collection technology with LLS’ research and focus on patient advocacy, with the goal of improving the oncology patient experience.
Frequent clinic visits and venipuncture blood draws are a burden on patients with leukemia, lymphoma, and other blood cell disorders. The effort of traveling to a distant clinic site for monitoring can be difficult for an ill patient, while in-person visits can present dangers for immunocompromised individuals. To reduce the burden on blood cancer patients, LLS and Tasso are collaborating on a clinical trial evaluating a new patient-centric strategy for collecting critical Complete Blood Count (CBC) using the Tasso device in blood cancer patients with low blood counts.